share_log

Reshape Lifesciences FY23 Sales $8.678M Miss $8.904M Estimate

Reshape Lifesciences FY23 Sales $8.678M Miss $8.904M Estimate

Reshape Lifesciences 23財年銷售額爲867.8萬美元,未達到預期的890.4萬美元
Moomoo 24/7 ·  04/01 16:08

Reshape Lifesciences (NASDAQ:RSLS) reported quarterly sales of $8.678 million which missed the analyst consensus estimate of $8.904 million by 2.54 percent.

Reshape Lifesciences(納斯達克股票代碼:RSLS)公佈的季度銷售額爲867.8萬美元,比分析師共識估計的890.4萬美元低2.54%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論